Arysana's leadership team has held industry-based executive positions within Value & Access from small biotech to large pharmaceutical companies
“At earlier stages of integration, companies still develop functional evidence generation plans bottom-up, and bring those plans together into an ‘integrated’ plan later.
While this is a good starting basis does not allow for the most efficient use of resources.
In addition, we notice that involvement of countries (timing and number) varies across the companies and is less systematic in terms of the involvement of smaller yet progressive countries.”
Consistent strategic roadmap facilitates cross-functional evidence generation planning & management
Research with the purpose and end goal in mind
Single source of truth, linking evidence, tactics and value messages
Global strategy for country needs adaptation
Multiple views and presentation-ready outputs one click away
Integrated with SharePoint
Targeted AI features for efficiency in evidence summaries and value narrative development